What question did this study set out to answer?

To summarize the recent advances in immunotherapy specific to head and neck cancers.

March 8, 2026Open Access

Recent highlights and breakthroughs in immunotherapy for head and neck cancers

Key Points

To summarize the recent advances in immunotherapy specific to head and neck cancers.
Review recent immunotherapy trials for head and neck cancers.
Assess the timing of immune checkpoint inhibitors in treatment protocols.
Evaluate combinations of immunotherapy with resistance-targeting agents and delivery techniques.
Positive outcomes reported in trials of immunotherapy for head and neck cancers.
Clinical benefits observed with earlier use of immune checkpoint inhibitors.
Combination therapies show promise in overcoming treatment resistance.

Abstract

Recent advances highlight a rapid surge in positive immunotherapy trials across different head and neck cancer entities, with clinical benefit observed both when immune checkpoint inhibitors are moved earlier in the disease course and when they are combined with agents targeting resistance mechanisms or enabling more precise drug delivery to tumors.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Joanna Vuille

Petr Szturz

Journals

Current Opinion in Oncology

Actions

Institutions

University of Lausanne

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Recent highlights and breakthroughs in immunotherapy for head and neck cancers

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider